Tianjin Zhongxin Pharmaceutical Group Corp Ltd Financial Flexibility Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd financial flexibility index. Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥131.84 Million (operating CF CN¥110.78 Million minus capex CN¥21.06 Million) represents 0% of total liabilities (CN¥2.56 Billion). See Tianjin Zhongxin Pharmaceutical Group Co (600329) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Financial flexibility index of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. Historical Financial Flexibility Index trend for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 24 annual periods. Check 600329 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Financial Flexibility Index by Year (2001–2024)
Tianjin Zhongxin Pharmaceutical Group Corp Ltd financial flexibility index by year from 2001 to 2024. Year-by-year free cash flow to debt coverage for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For the full cash flow conversion analysis, see Tianjin Zhongxin Pharmaceutical Group Co (600329) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.36x | CN¥1.04 Billion | CN¥924.67 Million | CN¥2.92 Billion | ▲ +54.4% |
| 2023 | 0.23x | CN¥829.42 Million | CN¥688.49 Million | CN¥3.58 Billion | ▲ +6.2% |
| 2022 | 0.22x | CN¥785.15 Million | CN¥677.25 Million | CN¥3.61 Billion | ▼ -44.9% |
| 2021 | 0.40x | CN¥1.01 Billion | CN¥852.40 Million | CN¥2.55 Billion | ▲ +7.2% |
| 2020 | 0.37x | CN¥860.58 Million | CN¥671.42 Million | CN¥2.33 Billion | ▲ +22.0% |
| 2019 | 0.30x | CN¥701.10 Million | CN¥495.49 Million | CN¥2.32 Billion | ▲ +17.8% |
| 2018 | 0.26x | CN¥525.95 Million | CN¥350.14 Million | CN¥2.05 Billion | ▲ +363.5% |
| 2017 | 0.06x | CN¥110.45 Million | CN¥-3.97 Million | CN¥2.00 Billion | ▼ -78.8% |
| 2016 | 0.26x | CN¥536.10 Million | CN¥419.90 Million | CN¥2.06 Billion | ▲ +12.8% |
| 2015 | 0.23x | CN¥453.22 Million | CN¥360.58 Million | CN¥1.96 Billion | ▲ +61.0% |
| 2014 | 0.14x | CN¥357.01 Million | CN¥286.85 Million | CN¥2.49 Billion | ▲ +34.8% |
| 2013 | 0.11x | CN¥285.86 Million | CN¥213.44 Million | CN¥2.69 Billion | ▲ +267.5% |
| 2012 | 0.03x | CN¥61.98 Million | CN¥20.81 Million | CN¥2.14 Billion | ▼ -74.1% |
| 2011 | 0.11x | CN¥216.90 Million | CN¥173.88 Million | CN¥1.94 Billion | ▼ -5.8% |
| 2010 | 0.12x | CN¥207.82 Million | CN¥139.04 Million | CN¥1.75 Billion | ▲ +31.2% |
| 2009 | 0.09x | CN¥170.15 Million | CN¥83.41 Million | CN¥1.88 Billion | ▼ -8.0% |
| 2008 | 0.10x | CN¥194.13 Million | CN¥155.77 Million | CN¥1.97 Billion | ▲ +183.4% |
| 2007 | 0.03x | CN¥73.87 Million | CN¥20.13 Million | CN¥2.13 Billion | ▲ +104.4% |
| 2006 | 0.02x | CN¥35.66 Million | CN¥-28.08 Million | CN¥2.10 Billion | ▼ -91.3% |
| 2005 | 0.20x | CN¥411.70 Million | CN¥261.91 Million | CN¥2.11 Billion | ▲ +51.4% |
| 2004 | 0.13x | CN¥262.80 Million | CN¥10.50 Million | CN¥2.04 Billion | ▼ -62.0% |
| 2003 | 0.34x | CN¥665.77 Million | CN¥76.57 Million | CN¥1.96 Billion | ▲ +21.8% |
| 2002 | 0.28x | CN¥368.00 Million | CN¥187.60 Million | CN¥1.32 Billion | ▲ +12.7% |
| 2001 | 0.25x | CN¥291.68 Million | CN¥157.73 Million | CN¥1.18 Billion | — |